Article Versions Notes

Imran KM, Tintera B, Morrison HA, Tupik JD, Nagai-Singer MA, Ivester H, Council-Troche M, Edwards M, Coutermarsh-Ott S, Byron C, et al. Improved Therapeutic Delivery Targeting Clinically Relevant Orthotopic Human Pancreatic Tumors Engrafted in Immunocompromised Pigs Using Ultrasound-Induced Cavitation: A Pilot Study. Pharmaceutics. 2023; 15(6):1585. https://doi.org/10.3390/pharmaceutics15061585

Imran, Khan Mohammad, Benjamin Tintera, Holly A. Morrison, Juselyn D. Tupik, Margaret A. Nagai-Singer, Hannah Ivester, McAlister Council-Troche, Michael Edwards, Sheryl Coutermarsh-Ott, Christopher Byron, and et al. 2023. "Improved Therapeutic Delivery Targeting Clinically Relevant Orthotopic Human Pancreatic Tumors Engrafted in Immunocompromised Pigs Using Ultrasound-Induced Cavitation: A Pilot Study" Pharmaceutics 15, no. 6: 1585. https://doi.org/10.3390/pharmaceutics15061585

Imran, K. M., Tintera, B., Morrison, H. A., Tupik, J. D., Nagai-Singer, M. A., Ivester, H., Council-Troche, M., Edwards, M., Coutermarsh-Ott, S., Byron, C., Clark-Deener, S., Uh, K., Lee, K., Boulos, P., Rowe, C., Coviello, C., & Allen, I. C. (2023). Improved Therapeutic Delivery Targeting Clinically Relevant Orthotopic Human Pancreatic Tumors Engrafted in Immunocompromised Pigs Using Ultrasound-Induced Cavitation: A Pilot Study. Pharmaceutics, 15(6), 1585. https://doi.org/10.3390/pharmaceutics15061585